Commentary
Video
Dr. Dmochowski on tibial nerve stimulation as an earlier line of therapy for OAB
Author(s):
Roger R. Dmochowski, MD, MMHC, highlights the FDA approval of the Revi System, specifically touching on how the device may be used as a potential earlier line of therapy for patients with OAB.
In this video, Roger R. Dmochowski, MD, MMHC, highlights the FDA approval of the BlueWind Revi System, specifically touching on how the device is being recognized as a potential earlier line of therapy for patients with overactive bladder (OAB). Dmochowski is the chief medical officer at BlueWind Medical as well as a professor of urology, gynecology, and surgery and Vanderbilt University Medical Center in Nashville, Tennesee.
Related Videos
Related Content
